Hear the latest news, learn about exciting research, and apply guidelines to stay at the leading edge of understanding and treating thyroid disease at a time of changing standards in diagnosis and care.
Unique Biomarkers Identified for Use in Thyroid Cancer Follow-Up January 2017 | Researchers have identified two unique biomarkers that show promise for monitoring patients who have received treatment for papillary thyroid cancer (PTC), according to a study recently published in the new open access Journal of the Endocrine Society…
Explore highlights of current education across the Endocrine Society.
New Treatments for Advanced Thyroid Cancer
CEU Satellite Symposium | 1.0 AMA PRA Category 1 Credits™ Lori J. Wirth, MD
Learn which patients are most likely to benefit from new MKI therapies and how to optimize treatment.
Congenital Hypothyroidism Practice Improvement Module: Diagnosis and Management
Practice Resource | 20 AMA PRA Category 1 Credits™ and ABIM MOC Part 4 points
Faculty: Rosalind S. Brown MD; Stephen LaFranchi, MD; Susan R. Rose, MD; and Ari Wassner, MD
Improve your screening and care for pediatric patients with primary CH using updated performance measures. Developed in partnership with the Pediatric Endocrine Society.
Thyroid Digital Toolkit
Patient Resource | No credit available
Reviewer: Alan P. Farwell, MD
Interactive and downloadable resources and information for patients with questions about thyroid health and disease.
Thyroid Ultrasound Workshops 2016
Workshop Webcast | 9.0 AMA PRA Category 1 Credits™ and ABIM MOC Part 2 points
Introductory Planning Chairs: Jennifer Sipos, MD and Joshua P. Klopper, MD
Advanced Planning Chair: Susan J. Mandel, MD, MPH
Improve your ultrasound skills with lessons on techniques for FNA and diagnostic testing, as well as guides to interpreting challenging results.
Endocrine Facts & Figures: Thyroid
Research Resource | No credit available
Advisory Panel Chair: Robert A. Vigersky, MD
Updated epidemiological data and in-depth discussion on several types of thyroid disease with current citations and expert insights.
Targeting MYC as a Therapeutic Intervention for Anaplastic Thyroid Cancer JCEM | March 28, 2017 Keisuke Enomoto, Xuguang Zhu, Sunmi Park, Li Zhao, Yuelin J. Zhu, Mark C. Willingham, Jun Qi, John A. Copland, Paul Meltzer, and Sheue-yann Cheng
Anaplastic thyroid cancer (ATC) is one of the most aggressive cancers in humans. Studies have shown that human ATC derives from complex and heterogeneous genetic changes, making effective treatment a major challenge…
Long-Term Quality of Life in Adult Survivors of Pediatric Differentiated Thyroid Carcinoma JCEM | December 21, 2016 Marloes Nies, Mariëlle S. Klein Hesselink, Gea A. Huizinga, Esther Sulkers, Adrienne H. Brouwers, Johannes G. M. Burgerhof, Eveline W. C. M. van Dam, Bas Havekes, Marry M. van den Heuvel-Eibrink, Eleonora P. M. Corssmit, Leontien C. M. Kremer, Romana T. Netea-Maier, Heleen J. H. van der Pal, Robin P. Peeters, John T. M. Plukker, Cécile M. Ronckers, Hanneke M. van Santen, Wim J. E. Tissing, Thera P. Links, and Gianni Bocca
The diagnosis and treatment of childhood cancer constitute a major life event that may influence psychosocial functioning and quality of life (QoL) long after initial treatment has been completed. Pediatric differentiated thyroid carcinoma (DTC) is a rare…
The Relationship Between Thyroid Function and the Prevalence of Type 2 Diabetes Mellitus in Euthyroid Subjects JCEM | December 01, 2016 Yeqing Gu, Huihui Li, Xue Bao, Qing Zhang, Li Liu, Ge Meng, Hongmei Wu, Huanmin Du, Hongbin Shi, Yang Xia, Qian Su, Liyun Fang, Fei Yu, Huijun Yang, Bin Yu, Shaomei Sun, Xing Wang, Ming Zhou, Qiyu Jia, Qi Guo, Hong Chang, Guolin Wang, Guowei Huang, Kun Song, and Kaijun Niu
Type 2 diabetes mellitus (T2DM) is the most common chronic endocrine disease, characterized by hyperglycemia resulting from impaired insulin secretion…
Targeting Autophagy Sensitizes BRAF-Mutant Thyroid Cancer to Vemurafenib JCEM | October 18, 2016 Weibin Wang, Helen Kang, Yinu Zhao, Irene Min, Brian Wyrwas, Maureen Moore, Lisong Teng, Rasa Zarnegar, Xuejun Jiang, and Thomas J. Fahey, III
Thyroid cancer incidence has increased significantly in recent years, and it is currently the fifth most frequently diagnosed…
Long-Term Recurrence of Small Papillary Thyroid Cancer and Its Risk Factors in a Korean Multicenter Study JCEM | October 12, 2016 Yul Hwangbo, Jung Min Kim, Young Joo Park, Eun Kyung Lee, You Jin Lee, Do Joon Park, Young Sik Choi, Kang Dae Lee, Seo Young Sohn, Sun Wook Kim, Jae Hoon Chung, Dong Jun Lim, Min Hee Kim, Min Joo Kim, Young Suk Jo, Min Ho Shong, Sung-Soo Koong, Jong Ryeal Hahm, Jung Hwa Jung, and Ka Hee Yi
Thyroid cancer is the most common malignancy in Korea. According to the statistics of the Korea Central Cancer Registry…
Management of Thyroid Dysfunction during Pregnancy and Postpartum JCEM | July 2, 2013 Leslie De Groot, Marcos Abalovich, Erik K. Alexander, Nobuyuki Amino, Linda Barbour, Rhoda H. Cobin, Creswell J. Eastman, John H. Lazarus, Dominique Luton, Susan J. Mandel, Jorge Mestman, Joanne Rovet, and Scott Sullivan
Practice guidelines are presented for diagnosis and treatment of patients with thyroid-related medical issues just before and during pregnancy and in the postpartum interval. These include evidence-based…
For additional meetings, visit the Endocrine Society’s Worldwide Endocrinology Calendar at endocrine.org/calendar.
ThyroAlex 5 Dates: July 7, 2017 Location: Alexandria, Egypt Sponsor: Alexandria Thyroid Association
Clinical Endocrinology Update & Endocrine Board Review Dates: September 23–27, 2017 Location: Chicago, Illinois, United States Sponsor: Endocrine Society
Whether you need the latest clinical information or you’re preparing to certify or recertify for the boards, Clinical Endocrinology Update (CEU) and Endocrine Board Review (EBR) have you covered.
ENDO Bridge Dates: October 19–22, 2017 Location: Antalya, Turkey Sponsor: Endocrine Society, the European Society of Endocrinology, and The Society of Endocrinology and Metabolism of Turkey
EndoBridge will provide a comprehensive update in the field of endocrinology for the clinical endocrinologist. The official language of the meeting is English, but simultaneous translation will be available in Russian, Arabic, and Turkish
ENDO 2018 Dates: March 17–20, 2018 Location: Chicago, Illinois, United States Sponsor: Endocrine Society
ENDO is the world’s largest event for presenting and obtaining the latest in endocrine science and medicine with an extensive program covering a broad array of topics, various networking opportunities, poster sessions, updates on new products and technologies at the ENDOExpo, and more.